In addition to Stifel Nicolaus, Tempus AI, Inc. Class A also received a Hold from Piper Sandler’s David Westenberg in a report issued today. However, on August 8, Needham reiterated a Buy rating on ...

Valneva confirmed its outlook for 2025, including expectations for total revenue between 180 million and 190 million euros. Total revenue last year was approximately 170 million euros. With Pfizer, ...

With the American consumer running out of breath amid an economic slowdown in the second half of 2025, Stifel sees a selloff of 10% or more in the S&P 500.

Stifel’s Barry Bannister says stocks are due for a big drop and thinks investors should play defense with staples and ...

Wall Street’s record-setting rally is due for a reality check, according to the latest report from Stifel’s Barry Bannister ...

Fintel reports that on August 8, 2025, Stifel downgraded their outlook for Crocs (NasdaqGS:CROX) from Buy to Hold. Analyst ...

Members of the team at Stifel posed with the Siouxland Chamber of Commerce and many others, on July 31, 2025, for a ribbon ...

Alcon Inc. (NYSE:ALC) ranks among the best medical stocks to buy according to analysts. On July 10, Stifel reaffirmed its Buy ...

Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best medical stocks to buy according to analysts. On July 25, Stifel ...

ST. LOUIS, June 11, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that Victor Nesi, Co-President and Head of the Institutional Group, will retire from his day-to-day ...

Stifel’s initiation of coverage on NewAmsterdam with a Buy rating and a $44 price target reflects their confidence in the company’s potential to outperform within the pharmaceutical industry ...

Stifel Financial completes acquisition of Bryan Garnier, enhancing European capabilities in technology and healthcare investment banking.